Sandra O’Toole

9.5k total citations · 1 hit paper
105 papers, 4.3k citations indexed

About

Sandra O’Toole is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sandra O’Toole has authored 105 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 52 papers in Molecular Biology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sandra O’Toole's work include Cancer Genomics and Diagnostics (18 papers), Lung Cancer Treatments and Mutations (18 papers) and Cancer Cells and Metastasis (11 papers). Sandra O’Toole is often cited by papers focused on Cancer Genomics and Diagnostics (18 papers), Lung Cancer Treatments and Mutations (18 papers) and Cancer Cells and Metastasis (11 papers). Sandra O’Toole collaborates with scholars based in Australia, United States and United Kingdom. Sandra O’Toole's co-authors include Robert L. Sutherland, Ewan K.A. Millar, Wendy A. Cooper, Christina Selinger, Catriona M. McNeil, Elizabeth A. Musgrove, Elena López‐Knowles, John D. Minna, David Lam and Alexander Swarbrick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Sandra O’Toole

102 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer

2015 478 citations Qian Wang, Kate Harvey et al. profile →

Peers

Countries citing papers authored by Sandra O’Toole

Since Specialization

Citations

This map shows the geographic impact of Sandra O’Toole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra O’Toole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra O’Toole more than expected).

Fields of papers citing papers by Sandra O’Toole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra O’Toole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra O’Toole. The network helps show where Sandra O’Toole may publish in the future.

Co-authorship network of co-authors of Sandra O’Toole

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra O’Toole. A scholar is included among the top collaborators of Sandra O’Toole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra O’Toole. Sandra O’Toole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer 2024 ·The EMBO Journal ·(unknown), (unknown), Qian Wang, (unknown), Lake‐Ee Quek, Angel Pang, (unknown), Mark Larance, Fabio Zanini, Kate Harvey, Sandra O’Toole, Yi Fang Guan, Jeff Holst	5
2	Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), Jessica Vieusseux, (unknown), Cameron N. Johnstone, (unknown), Sandra O’Toole, Lisa M. Ooms, Christina A. Mitchell, Robin L. Anderson, Kara L. Britt	3
3	ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1 2021 ·Pathology ·(unknown), (unknown), (unknown), (unknown), (unknown), Laveniya Satgunaseelan, Andrew J. Colebatch, Annabelle Mahar, Ruta Gupta, Sandra O’Toole, Wendy A. Cooper	6
4	Updates in the molecular pathology of non-small cell lung cancer 2021 ·Seminars in Diagnostic Pathology ·Elizabeth C. Paver, Sandra O’Toole, Xin Cheng, Annabelle Mahar, Wendy A. Cooper	14
5	The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome 2018 ·Clinical Cancer Research ·Carmela Ricciardelli, Tina Bianco‐Miotto, Shalini Jindal, Lisa M. Butler, Samuel Leung, Catriona M. McNeil, Sandra O’Toole, Esmaeil Ebrahimie, Ewan K.A. Millar, Andrew J. Sakko, (unknown), Sarah L. Vowler, David G. Huntsman, Stephen N. Birrell, Robert L. Sutherland, Carlo Palmieri, Theresa E. Hickey, Wayne D. Tilley	62
6	Optimise not compromise: The importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery 2018 ·Critical Reviews in Oncology/Hematology ·(unknown), Thiru Prasanna, Youlia Kirova, S. Alran, Sandra O’Toole, Jane Beith, Philip Poortmans, Catriona M. McNeil, Susan Carroll	10
7	miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense 2017 ·Cancer Research ·Marina Pajic, Danielle Froio, Sheridan Daly, (unknown), Ewan K.A. Millar, Peter Graham, Alison Drury, Angela Steinmann, Charles E. de Bock, Alice Boulghourjian, Anaiis Zaratzian, Susan Carroll, Joanne Toohey, Sandra O’Toole, Adrian L. Harris, Francesca M. Buffa, Harriet E. Gee, Georgina E. Hollway, Timothy J. Molloy	110
8	The molecular profile of metastatic melanoma in Australia 2016 ·Pathology ·Megan Lyle, Lauren E. Haydu, Alexander M. Menzies, John F. Thompson, Robyn P.M. Saw, Andrew J. Spillane, Richard Kefford, Graham J. Mann, Wendy A. Cooper, Bing Yu, Richard A. Scolyer, Sandra O’Toole, Georgina V. Long	17
9	Targeting the hedgehog signalling pathway in triple negative breast cancer 2015 ·Annals of Oncology ·Mun N. Hui, Aurélie Cazet, (unknown), Caroline Cooper, Andrea McFarland, Radhika Nair, Sandra O’Toole, Alexander Swarbrick	2
10	Methylation profiling of ductal carcinoma in situand its relationship to histopathological features 2014 ·Breast Cancer Research ·Jia‐Min Pang, Siddhartha Deb, Elena A. Takano, David J. Byrne, Nicholas Jene, Alice Boulghourjian, (unknown), Ewan K.A. Millar, C. Soon Lee, Sandra O’Toole, Alexander Dobrovic, Stephen B. Fox	16
11	Cell cycle marker expression in benign and malignant intraductal papillary lesions of the breast 2014 ·Journal of Clinical Pathology ·(unknown), Caroline Cooper, Christina Selinger, Elizabeth H Barnes, Charles Chan, Hugh Carmalt, Richard H. West, Laurence Gluch, Jane Beith, C. Elizabeth Caldon, Sandra O’Toole	11
12	Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas 2014 ·Pathology ·Hojabr Kakavand, (unknown), Trina Lum, Sandra O’Toole, Richard Kefford, John F. Thompson, James S. Wilmott, Georgina V. Long, Richard A. Scolyer	16
13	Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer 2014 ·Journal of Clinical Pathology ·(unknown), (unknown), Bing Yu, (unknown), Maija R.J. Kohonen‐Corish, Brian C. McCaughan, Catherine J. Kennedy, Sandra O’Toole, Wendy A. Cooper	12
14	Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer 2014 ·Pathology ·(unknown), Christopher W. Toon, Adele Clarkson, Loretta Sioson, Nicole Watson, Mahtab Farzin, Christina Selinger, Angela Chou, Adrienne Morey, Wendy A. Cooper, Sandra O’Toole, Anthony J. Gill	29
15	Transcription factor ATF3 links host adaptive response to breast cancer metastasis 2013 ·Journal of Clinical Investigation ·(unknown), Stephen J. McConoughey, Swati Jalgaonkar, Marino E. Leon, Anand S. Merchant, (unknown), Xin Yin, (unknown), Erik Zmuda, Sandra O’Toole, Ewan K.A. Millar, (unknown), Charles L. Shapiro, Michael C. Ostrowski, Robert L. Sutherland, Tsonwin Hai	96
16	Classification, morphology and molecular pathology of premalignant lesions of the pancreas 2013 ·Pathology ·Caroline Cooper, Sandra O’Toole, James G. Kench	51
17	The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression 2011 ·Breast Cancer Research ·Peter Chan, Andreas Möller, Mira C.P. Liu, Jaclyn Sceneay, (unknown), Nicola Waddell, (unknown), Alexander Dobrovic, Ewan K.A. Millar, Sandra O’Toole, Catriona M. McNeil, Robert L. Sutherland, David D.L. Bowtell, Stephen B. Fox	44
18	Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells 2010 ·Cancer Research ·Falko Hochgräfe, Luxi Zhang, Sandra O’Toole, Brigid C. Browne, Mark Pinese, (unknown), Gillian M. Lehrbach, David R. Croucher, Danny Rickwood, Alice Boulghourjian, Robert F. Shearer, Radhika Nair, Alexander Swarbrick, Dana Faratian, Peter Mullen, David J. Harrison, Andrew V. Biankin, Robert L. Sutherland, Mark J. Raftery, Roger J. Daly	141
19	High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtype 2010 ·Histopathology ·(unknown), Ibrahim M. Zardawi, Catriona M. McNeil, Ewan K.A. Millar, Duncan McLeod, Adrienne Morey, Paul Crea, Niamh Murphy, Mark Pinese, Elena López‐Knowles, Samantha R. Oakes, Christopher J. Ormandy, Min Qiu, Anne Hamilton, Andrew J. Spillane, Cheok Soon Lee, Robert L. Sutherland, Elizabeth A. Musgrove, Sandra O’Toole	48
20	Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. 2009 ·PubMed ·(unknown), Sandra O’Toole, Robert L. Sutherland, Elizabeth A. Musgrove	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact